Convergent Therapeutics

Oncology

Dr Philip Kantoff, a world-renowned prostate cancer clinician and researcher, discusses alpha radiopharma treatment possibilities.

News

Arrowhead Pharma is squaring up to rival Ionis in the severe hypertriglyceridaemia (sHTG) market, drawing on phase 3 data at ESC 2026.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.